Hjem › Hjerteanfald › Tennessee
Hjerteanfald kliniske forsøg i Tennessee
5 studier for Hjerteanfald søger deltagere på steder i Tennessee.
Byer i Tennessee
Officiel studietekst (engelsk)
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
- Southeast Renal Research Institute, Chattanooga
- Dialysis Clinic Inc - University Nephology, Knoxville
- Knoxville Kidney Center PLLC, Knoxville
- og 2 flere
RekruttererFase 2/3
Alder 18 og opefter · Alle køn · Opdateret 21. sep. 2026 · NCT05485961An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
- The Stern Cardiovascular Foundation, Germantown
- Apex Cardiology Research Associates of Jackson, Jackson
- Vanderbilt Univ Medi Cen, Nashville
- og 1 flere
RekruttererFase 3
Alder 18 til 100 · Alle køn · Opdateret 4. sep. 2026 · NCT07517263OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
- Erlanger Health, Inc., Chattanooga
- Ascension Saint Thomas, Nashville
- Parkway Cardiology Associates, Oak Ridge
- og 1 flere
RekruttererFase 3
Alder 50 til 105 · Alle køn · Opdateret 21. aug. 2026 · NCT07136012Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk
- Vanderbilt University Medical Center, Nashville
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 24. mar. 2026 · NCT04774159Pharmacy-led Transitions of Care Intervention to Improve Medication Adherence
- University of Tennessee Medical Center, Knoxville
- University of Tennessee Health Science Center/Regional One Health, Memphis
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 29. jan. 2026 · NCT06374277Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.